Abstract Submission
2024 Global Meeting – In collaboration with ASSBI, FESN and SLAN Porto, Portugal | July 3 – 5, 2024 Abstract Submission INS Membership is not required for abstract submission. However, you must be logged in to submit an abstract. If you are brand new to INS and have never logged in, you may create a […]
Abstract Submission
Abstract Submission INS Membership is not required for abstract submission. However, you must be logged in to submit an abstract. If you are brand new to INS and have never logged in, you may create a guest account. INS members will receive discounts on meeting registration and CE fees (if 2024 annual dues are paid […]
Student Liaison Committee
Welcome to INS-SLC Thank you for visiting the page of the INS Student Liaison Committee! You may read about the history of SLC and about our student committee members on this page, or connect with the INS-SLC on their Facebook page. Click here to connect with INS-SLC on Facebook The INS Student Liaison Committee also operates a […]
Frontotemporal dementia: Assessment, management and considerations for culturally diverse and low resource settings
You must be logged in and have sufficient permission to access this content.
Episode 82 | Neuropsychological Norms for Spanish Speaking People in the U.S. – With Dr. Maria Marquine
This episode is a conversation about neuropsychological norms for Spanish speaking people who reside in the U.S. It focuses on the NP-NUMBRS project, which provides norms for a multidomain cognitive battery completed by Spanish speakers from the U.S.-Mexico border region. Additional topics covered include shared aspects of Hispanic/Latinx culture that are relevant to neuropsychologists, the importance of co-normed cognitive batteries in neuropsychology, and cognitive effects of bilingualism, among others.
Episode 74 | Global Neuropsychology: Introduction – With Dr. Tedd Judd
This episode covers cultural neuropsychology and global neuropsychology. We talk with Tedd Judd, Ph.D., ABPP-CN, about how neuropsychology in North Atlantic countries is unique relative to how neuropsychology is practiced elsewhere. We also discuss advice for conducting competent clinical evaluations with patients whose culture is unfamiliar to the clinician.
Episode 30 | The NIH Toolbox – With Dr. Julie Hook
Dr. Hook is a Research Associate Professor in the Department of Medical Social Sciences at the Northwestern University Feinberg School of Medicine, and is Product Manager of the NIH Toolbox®. She participates in grant funded research and directs the marketing efforts and strategic direction for the NIH Toolbox. Her interests in test development and combining innovative technologies to assist in neuropsychological assessment has led her to positions in both academia and industry. She was previously an Assistant Professor at Rush University (Chicago, IL) and worked in R & D at Psychological Assessment Resources (PAR; Lutz, FL), both a Project Director and Manager of Quality Assurance. While working in Medical Innovation for Design Interactive, an SBIR-funded human factor engineering company (Orlando, FL), she led a number of innovative DoD grants aimed at incorporating technology (e.g., virtual reality, eye-tracking, and machine learning) into medical practice and training.
Episode 78 | Neuropsychology and Sub-Saharan Africa – With Drs. Jean Ikanga and Tony Stringer
Culturally informed neuropsychological evaluations require that clinicians develop knowledge of the macrosocietal structures of unfamiliar countries and the cultural backgrounds of their patients. Sub-Saharan Africa is a large region, with over one billion people, some of whom develop neurological conditions and could benefit from neuropsychological services. In this episode, we discuss shared aspects of sub-Saharan culture, particularly in contrast to Western norms, and we introduce and describe the African Neuropsychological Battery. The overarching goal of the episode is to help listeners increase awareness and knowledge of important cultural factors.
Episode 33 | Neuropsychology 3.0 – With Dr. Robert Bilder
Research has repeatedly demonstrated the benefits of neuropsychological evaluations to patients and their families. However, there is great potential for advancement and improvement in the field. For example, there is growing interest in improving the validity of neuropsychological tests in the assessment and prediction of complex medical conditions using biological, statistical, and informatic techniques. We discuss these issues with Robert “Bob” Bilder, Ph.D., ABPP-CN, a leader in the conceptual and technical evolution of the field. We also discuss the problem of inertia, ecological and physiological validity, item response theory, computerized neuropsychological testing, and the National Neuropsychology Network (NNN).
Episode 19 | Redefining Alzheimer’s Disease: Does Cognition Matter? – With Dr. Adam Brickman
The estimated annual cost of healthcare for individuals living with Alzheimer’s disease (AD) or other dementias is almost $300 billion. In addition to this financial burden, the number of adults aged 65 or older is projected to double and it is expected an estimated 10 million of these individuals will develop AD by 2050. Despite global efforts to understand and ultimately assess, diagnose, and treat Alzheimer’s disease (AD) more effectively, a consensus definition of AD still does not exist. In 2018, the National Institute of Aging – Alzheimer’s Association (NIA-AA) Research Framework recommended that we should shift the definition of AD from a syndrome (i.e., the cognitive/behavioral symptoms that individuals present with) to a purely biological construct, specifically the presence of βamyloid deposition, pathologic tau, and neurodegeneration (the “A/T/N” model). In this episode, we talk with Dr. Adam Brickman about the NIA-AA Research Framework biological definition of AD, the role of vascular contributions, assumptions about the amyloid hypothesis, and implications of not including the clinical syndrome in the diagnosis of AD.